Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials

• Үндсэн зохиолчид: Haihuan Feng (Зохиогч), Ying Zhao (Зохиогч), Weihong Kuang (Зохиогч), Yanping Dai (Зохиогч), Xiaobo Cen (Зохиогч), Feng Qin (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Objective: Tumor necrosis factor alpha inhibitors (TNFi) have shown substantial efficacy in alleviating and treating ankylosing spondylitis (AS). However, the heightened interest is accompanied by concerns over adverse events. In this meta-analysis, we analyzed both serious and common adverse events...